These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 21943334)
1. The interaction of the second Kunitz-type domain (KD2) of TFPI-2 with a novel interaction partner, prosaposin, mediates the inhibition of the invasion and migration of human fibrosarcoma cells. Xu C; Deng F; Mao Z; Zhang J; Wang H; Wang J; Mu J; Deng S; Ma D Biochem J; 2012 Jan; 441(2):665-74. PubMed ID: 21943334 [TBL] [Abstract][Full Text] [Related]
2. Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2. Rao CN; Reddy P; Reeder DJ; Liu Y; Stack SM; Kisiel W; Woodley DT Biochem Biophys Res Commun; 2000 Oct; 276(3):1286-94. PubMed ID: 11027624 [TBL] [Abstract][Full Text] [Related]
3. The role of tissue factor pathway inhibitor-2 in cancer biology. Sierko E; Wojtukiewicz MZ; Kisiel W Semin Thromb Hemost; 2007 Oct; 33(7):653-9. PubMed ID: 18000791 [TBL] [Abstract][Full Text] [Related]
4. Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo. Jin M; Udagawa K; Miyagi E; Nakazawa T; Hirahara F; Yasumitsu H; Miyazaki K; Nagashima Y; Aoki I; Miyagi Y Gynecol Oncol; 2001 Nov; 83(2):325-33. PubMed ID: 11606093 [TBL] [Abstract][Full Text] [Related]
5. Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo. Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J J Surg Res; 2011 May; 167(1):62-9. PubMed ID: 20018303 [TBL] [Abstract][Full Text] [Related]
6. Structure, function and biology of tissue factor pathway inhibitor-2. Chand HS; Foster DC; Kisiel W Thromb Haemost; 2005 Dec; 94(6):1122-30. PubMed ID: 16411383 [TBL] [Abstract][Full Text] [Related]
7. Identification of prosaposin as a novel interaction partner for Rhox5. Guo F; Huang X; Li S; Sun L; Li Y; Li H; Zhou Y; Chu Y; Zhou T J Genet Genomics; 2007 May; 34(5):392-9. PubMed ID: 17560524 [TBL] [Abstract][Full Text] [Related]
8. Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration. Zhao B; Luo X; Shi H; Ma D Thromb Res; 2011 Aug; 128(2):179-85. PubMed ID: 21458846 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of TFPI-2 promotes migration and invasion of glioma cells. Gessler F; Voss V; Seifert V; Gerlach R; Kögel D Neurosci Lett; 2011 Jun; 497(1):49-54. PubMed ID: 21530612 [TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells. Xu Z; Maiti D; Kisiel W; Duh EJ Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682 [TBL] [Abstract][Full Text] [Related]